2023 Q2 Form 10-Q Financial Statement

#000084485623000016 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $13.57M $13.56M $5.049M
YoY Change 121.38% 168.59% 45.67%
Cost Of Revenue $8.493M $8.645M $3.076M
YoY Change 123.44% 181.05% 55.75%
Gross Profit $5.082M $4.914M $1.973M
YoY Change 118.02% 149.14% 32.32%
Gross Profit Margin 37.43% 36.24% 39.07%
Selling, General & Admin $8.261M $6.897M $3.327M
YoY Change 123.32% 107.29% 64.49%
% of Gross Profit 162.57% 140.35% 168.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $374.0K $142.6K $193.3K
YoY Change 487.58% -26.26% 41.52%
% of Gross Profit 7.36% 2.9% 9.8%
Operating Expenses $8.261M $6.897M $3.327M
YoY Change 123.32% 107.29% 64.49%
Operating Profit -$3.180M -$1.983M -$1.355M
YoY Change 132.36% 46.36% 154.6%
Interest Expense $97.31K $93.19K $20.11K
YoY Change 482.35% 363.4% -142.98%
% of Operating Profit
Other Income/Expense, Net $429.6K $75.75K $36.99K
YoY Change 1777.21% 104.77% -122.54%
Pretax Income -$2.653M -$1.907M -$1.318M
YoY Change 97.16% 44.72% 89.29%
Income Tax
% Of Pretax Income
Net Earnings -$2.744M -$1.907M -$1.318M
YoY Change 103.96% 44.72% 89.29%
Net Earnings / Revenue -20.22% -14.07% -26.1%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 463.3B 346.3B 339.7B
Diluted Shares Outstanding 353.9B 341.7B 339.7B

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.483M $19.77M $20.61M
YoY Change -56.16% -4.09% 284.24%
Cash & Equivalents $8.482M $21.49M $20.59M
Short-Term Investments $1.370K $5.310K $26.66K
Other Short-Term Assets $2.460M $944.5K $298.8K
YoY Change 907.35% 216.13% 25.62%
Inventory $3.765M $3.967M $2.370M
Prepaid Expenses
Receivables $92.65K $100.6K $37.51K
Other Receivables $156.3K $172.9K $234.2K
Total Short-Term Assets $14.96M $27.26M $23.56M
YoY Change -32.89% 15.74% 220.03%
LONG-TERM ASSETS
Property, Plant & Equipment $13.61M $3.097M $6.696M
YoY Change 775.43% -53.76% 2902.85%
Goodwill $5.747M $5.747M
YoY Change 116.3%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $481.4K $475.4K $112.9K
YoY Change 303.28% 321.18% 27.41%
Total Long-Term Assets $24.38M $25.10M $11.88M
YoY Change 111.22% 111.26% 79.31%
TOTAL ASSETS
Total Short-Term Assets $14.96M $27.26M $23.56M
Total Long-Term Assets $24.38M $25.10M $11.88M
Total Assets $39.34M $52.36M $35.43M
YoY Change 16.28% 47.76% 153.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.133M $4.977M $2.059M
YoY Change 136.44% 141.75% 152.97%
Accrued Expenses $1.966M $2.036M $607.1K
YoY Change 249.0% 235.42% 25.57%
Deferred Revenue $147.5K $200.4K
YoY Change 162.84%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.005M $543.9K $455.9K
YoY Change 120.75% 19.32% -45.87%
Total Short-Term Liabilities $8.624M $9.008M $3.366M
YoY Change 165.69% 167.65% 55.98%
LONG-TERM LIABILITIES
Long-Term Debt $2.098M $2.239M $140.00
YoY Change 1599217.14% -99.98%
Other Long-Term Liabilities $8.395M $8.657M $4.153M
YoY Change 109.04% 108.46% 38.37%
Total Long-Term Liabilities $10.49M $2.239M $4.153M
YoY Change 161.28% -46.09% 9.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.624M $9.008M $3.366M
Total Long-Term Liabilities $10.49M $2.239M $4.153M
Total Liabilities $19.12M $19.90M $7.519M
YoY Change 163.25% 164.73% 26.63%
SHAREHOLDERS EQUITY
Retained Earnings -$48.17M -$45.52M
YoY Change 23.33%
Common Stock $46.33M $34.64M
YoY Change 36.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.22M $18.96M $27.92M
YoY Change
Total Liabilities & Shareholders Equity $39.34M $52.36M $35.43M
YoY Change 16.28% 47.76% 153.37%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$2.744M -$1.907M -$1.318M
YoY Change 103.96% 44.72% 89.29%
Depreciation, Depletion And Amortization $374.0K $142.6K $193.3K
YoY Change 487.58% -26.26% 41.52%
Cash From Operating Activities -$1.314M -$2.344M -$679.6K
YoY Change 10.31% 244.94% 3.54%
INVESTING ACTIVITIES
Capital Expenditures $21.78K $126.3K -$127.3K
YoY Change -125.37% -199.19%
Acquisitions
YoY Change
Other Investing Activities $16.61K $16.32K -$5.136M
YoY Change 24.42% -100.32% -39069.88%
Cash From Investing Activities -$5.170K -$109.9K -$5.264M
YoY Change -92.87% -97.91% 29675.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.06M -742.2K 34.56K
YoY Change 1702100.0% -2247.47% -98.87%
NET CHANGE
Cash From Operating Activities -1.314M -2.344M -679.6K
Cash From Investing Activities -5.170K -109.9K -5.264M
Cash From Financing Activities -11.06M -742.2K 34.56K
Net Change In Cash -12.38M -3.196M -5.909M
YoY Change 879.4% -45.9% -347.15%
FREE CASH FLOW
Cash From Operating Activities -$1.314M -$2.344M -$679.6K
Capital Expenditures $21.78K $126.3K -$127.3K
Free Cash Flow -$1.336M -$2.471M -$552.4K
YoY Change 20.85% 347.28% -15.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5048553
CY2023Q1 us-gaap Gross Profit
GrossProfit
4914391
CY2022Q1 us-gaap Gross Profit
GrossProfit
1972514
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
6897438
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
3327420
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1983047
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1354906
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
341671076830
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
341671076830
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
339741632384
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
339741632384
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000844856
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13559744
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-4457
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
3514
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17450
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16874
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
97653
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
16603
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
75746
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36991
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1907301
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1317915
CY2023Q1 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
61000
CY2022Q1 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
0
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1968301
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 hcmc Accrued Payment Of Induced Conversions Of Preferred Stock
AccruedPaymentOfInducedConversionsOfPreferredStock
6000
CY2022Q1 hcmc Accrued Payment Of Induced Conversions Of Preferred Stock
AccruedPaymentOfInducedConversionsOfPreferredStock
0
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Reclassification</span></div> <div><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Certain amounts in the condensed consolidated financial statements and related notes have been reclassified to conform to the current year presentation. Such reclassifications do not impact the Company's previously reported financial position or net income (loss). $75,000 inventory shrink was originally presented in the statement of cash flow under change in operating assets inventory in cash used in operating activities for three months ended March 31, 2022, it was reclassified to <span style="-sec-ix-hidden:Fact_e3e3a10e63a2480fa55f6eb5b59c4c40">write-down of obsolete and slow-moving inventory</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">under cash used in operating activities in the statement of cash flow.</span></div>
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13559744
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5048553
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13559744
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5048553
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1983047
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1354906
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
50000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0

Files In Submission

Name View Source Status
hcmc-20230331_pre.xml Edgar Link unprocessable
0000844856-23-000016-index-headers.html Edgar Link pending
0000844856-23-000016-index.html Edgar Link pending
0000844856-23-000016.txt Edgar Link pending
0000844856-23-000016-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
hcmc-20230331.xsd Edgar Link pending
image00001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
hcmc-20230331_cal.xml Edgar Link unprocessable
hcmc-20230331_def.xml Edgar Link unprocessable
hcmc-20230331_lab.xml Edgar Link unprocessable
form10q_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable